[{"from": "human", "value": "What can you tell me about this molecule? [C][=C][C][=C][Branch2][Ring2][=Branch1][N][C@@H1][Branch2][Ring1][N][C@@H1][Branch1][Branch1][C][Ring1][Ring2][=O][N][C][=Branch1][C][=O][/C][=Branch1][Ring1][=N][\\O][/C][=C][S][C][=Branch1][Ring2][=N][Ring1][Branch1][N][S][C][Ring2][Ring1][Branch1][C][=Branch1][C][=O][O]"}, {"from": "gpt", "value": "The molecule is a semi-synthetic, broad-spectrum antibiotic belonging to the third generation of the cephalosporin class. It has been proven to be effective for the treatment of common bacterial infections in the ear, sinus, throat, lungs, and skin. Cefdinir was approved by the FDA in 1997 to treat a variety of mild to moderate infections and was initially marketed by Abbvie. Because of its chemical structure, it is effective against organisms that are resistant to first-line cephalosporin therapy due to the production of beta-lactamase enzymes."}]